The Future of Drug Development: 3D Vascularized Tissue Models in Clinical Trials

In this episode, I talked to Dr. Karolina Valente, CEO of Voxcell BioInnovation. Dr. Valente talks about how her company, Voxcell, is trying to revolutionize the drug development process by developing customizable 3D tissue models to test different therapeutics and drugs. We also talked about how AI will affect future drug trials, Vancouver's potential as a biotech hub, improvements needed to strengthen Canada's biotech industry, Voxcell's new and old products, and the difficulty of raising money to go to different rounds.

---------------------------------------------------------------

Thanks to the sponsors:

Audible: Use my link for a 30-day free trial: http://audibletrial.com/diamondgoat

Newsly: https://newsly.me

promo code to receive a 1-month free premium subscription: EARLYMORNING

Libysn: https://libsyn.com

promo code: DG

Dubby Energy: https://www.dubby.gg

promo code for 10% off: DIAMONDGOAT

Opus Clips:  https://www.opus.pro/?via=diamondgoat

----------------------------------------------------------------------------------